Mark L Baum - Net Worth and Insider Trading

Mark L Baum Net Worth

The estimated net worth of Mark L Baum is at least $28 Million dollars as of 2024-05-13. Mark L Baum is the CHIEF EXECUTIVE OFFICER of Harrow Inc and owns about 2,137,525 shares of Harrow Inc (HROW) stock worth over $25 Million. Mark L Baum is the Director of Eton Pharmaceuticals Inc and owns about 794,745 shares of Eton Pharmaceuticals Inc (ETON) stock worth over $3 Million. Mark L Baum is also the Director of Ideal Power Inc and owns about 2,906 shares of Ideal Power Inc (IPWR) stock worth over $21,795. Details can be seen in Mark L Baum's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark L Baum has not made any transactions after 2024-03-22 and currently still holds the listed stock(s).

Transaction Summary of Mark L Baum

To

Mark L Baum Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark L Baum owns 6 companies in total, including Harrow Inc (HROW) , Eton Pharmaceuticals Inc (ETON) , and Ideal Power Inc (IPWR) among others .

Click here to see the complete history of Mark L Baum’s form 4 insider trades.

Insider Ownership Summary of Mark L Baum

Ticker Comapny Transaction Date Type of Owner
HROW Harrow Inc 2024-03-22 director & 10 percent owner & Chief Executive Officer
ETON Eton Pharmaceuticals Inc 2018-11-15 director
IPWR Ideal Power Inc 2017-03-03 director
2007-05-28 director & President
2006-10-03 other: General Counsel
2003-12-20 director & 10 percent owner & CEO

Mark L Baum Latest Holdings Summary

Mark L Baum currently owns a total of 3 stocks. Among these stocks, Mark L Baum owns 2,137,525 shares of Harrow Inc (HROW) as of March 22, 2024, with a value of $25 Million and a weighting of 90.02%. Mark L Baum owns 794,745 shares of Eton Pharmaceuticals Inc (ETON) as of November 15, 2018, with a value of $3 Million and a weighting of 9.9%. Mark L Baum also owns 2,906 shares of Ideal Power Inc (IPWR) as of March 3, 2017, with a value of $21,795 and a weighting of 0.08%.

Latest Holdings of Mark L Baum

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HROW Harrow Inc 2024-03-22 2,137,525 11.60 24,795,290
ETON Eton Pharmaceuticals Inc 2018-11-15 794,745 3.43 2,725,975
IPWR Ideal Power Inc 2017-03-03 2,906 7.50 21,795

Holding Weightings of Mark L Baum


Mark L Baum Form 4 Trading Tracker

According to the SEC Form 4 filings, Mark L Baum has made a total of 4 transactions in Harrow Inc (HROW) over the past 5 years, including 4 buys and 0 sells. The most-recent trade in Harrow Inc is the acquisition of 9,000 shares on March 22, 2024, which cost Mark L Baum around $104,310.

According to the SEC Form 4 filings, Mark L Baum has made a total of 0 transactions in Eton Pharmaceuticals Inc (ETON) over the past 5 years. The most-recent trade in Eton Pharmaceuticals Inc is the acquisition of 10,000 shares on November 15, 2018, which cost Mark L Baum around $60,000.

According to the SEC Form 4 filings, Mark L Baum has made a total of 0 transactions in Ideal Power Inc (IPWR) over the past 5 years. The most-recent trade in Ideal Power Inc is the acquisition of 780 shares on March 3, 2017, which cost Mark L Baum around $19,812.

Insider Trading History of Mark L Baum

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mark L Baum Trading Performance

GuruFocus tracks the stock performance after each of Mark L Baum's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark L Baum is 7.16%. GuruFocus also compares Mark L Baum's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark L Baum within 3 months outperforms 4 times out of 6 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mark L Baum's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mark L Baum

Average Return

Average return per transaction

Outperforming Transactions

0 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.44
Relative Return to S&P 500(%) 8.59

Mark L Baum Ownership Network

Ownership Network List of Mark L Baum

No Data

Ownership Network Relation of Mark L Baum


Mark L Baum Owned Company Details

What does Harrow Inc do?

Who are the key executives at Harrow Inc?

Mark L Baum is the director & 10 percent owner & Chief Executive Officer of Harrow Inc. Other key executives at Harrow Inc include 10 percent owner Opaleye Management Inc. , VP & Accounting and Reporting Andrew Boll , and director & 10 percent owner & Chairman of the Board Robert J Kammer .

Harrow Inc (HROW) Insider Trades Summary

Over the past 18 months, Mark L Baum made 4 insider transaction in Harrow Inc (HROW) with a net purchase of 47,300. Other recent insider transactions involving Harrow Inc (HROW) include a net purchase of 646,183 shares made by Opaleye Management Inc. , a net purchase of 45,000 shares made by Martin A. Makary , and a net purchase of 2,500 shares made by Andrew Boll .

In summary, during the past 3 months, insiders sold 0 shares of Harrow Inc (HROW) in total and bought 179,000 shares, with a net purchase of 179,000 shares. During the past 18 months, 0 shares of Harrow Inc (HROW) were sold and 742,843 shares were bought by its insiders, resulting in a net purchase of 742,843 shares.

Harrow Inc (HROW)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Harrow Inc Insider Transactions

No Available Data

Mark L Baum Mailing Address

Above is the net worth, insider trading, and ownership report for Mark L Baum. You might contact Mark L Baum via mailing address: C/o Imprimis Pharmaceuticals, Inc, 12264 El Camino Real, Suite 350, San Diego Ca 92130.

Discussions on Mark L Baum

No discussions yet.